Faisal already controls the voting power
This is my personal view:
Faisal already controls the voting power, so I expect all proposals to pass on July 16. I also think the reverse split will most likely be implemented after FDA approval rather than before, followed by the issuance of new shares.
The interesting part is the period between July 16 and July 29. In my opinion, he would like to grant himself a new warrant package. However, the recent price action seems to be moving in the wrong direction for that plan.
If the stock continues to rise, he may have no choice but to cover part of his short exposure using the existing $0.58 warrants. That would be a classic dilemma: the higher the share price goes, the more expensive it becomes to establish a new warrant position on attractive terms.
As for me, I'm holding my shares until the FDA decision. If a short squeeze develops, combined with the market's greed around the approval event and the expected reverse split, things could become very interesting.
u/volleasy — 1 month ago
2nd Part of the Avastin Story -Off Label abuse in the german Journal "Pharmarecht"
Written by the former president of BAS. That is why they do not generate any significant revenue in Germany. Bob Jahr’s strategy to enter the market alongside Avastin has failed. The only option would have been to take legal action against the off-label use of Avastin. However, Outlook rejected the approach proposed by a consulting firm. That firm had also predicted the disaster. Sales potential for Lytenava alone in Germany: 150 million per year.
Translated with DeepL.com (free version)
u/volleasy — 3 months ago